![🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024](https://cddf.org/wp-content/uploads/2024/07/Capture-3-1080x459.jpg)
![🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024](https://cddf.org/wp-content/uploads/2024/07/Capture-3-1080x459.jpg)
![[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]](https://cddf.org/wp-content/uploads/2024/07/Capture-2-1080x675.jpg)
[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]
The Cancer Drug Development Forum (CDDF) held a live webinar on Cancer Medicines Forum on 25 June 2024. In this webinar, Denis Lacombe (EORTC, BE) provided an interesting talk followed by a Q&A discussion moderated by Rosa Giuliani (CDDF, UK) and Daniel Goldstein...![ACT EU: Materials from MSP AG Meeting – 4 July 2024](https://cddf.org/wp-content/uploads/2024/07/Capture-1.jpg)
ACT EU: Materials from MSP AG Meeting – 4 July 2024
Check out presentation slides from the MSP AG Meeting that took place on 4 July 2024 and stay up to date on topics of interest for clinical trials in the EU. Multi-stakeholder platform – European Union (europa.eu)![ACT EU: Faster Access to Clinical Trial Information in Europe](https://cddf.org/wp-content/uploads/2024/06/Capture-1-1080x337.jpg)
ACT EU: Faster Access to Clinical Trial Information in Europe
The launch of a new version of the Clinical Trials Information System (CTIS) is giving earlier and more efficient access to clinical trial information in Europe. Revised transparency rules eliminate deferral mechanisms providing public access to approximately 4000...![ACT EU: Two New Advice Pilots to Improve Clinical Trials in Europe](https://cddf.org/wp-content/uploads/2024/06/Capture-1080x341.jpg)